Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:insulin
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:associatedWith |
gptkb:Lantus
|
| gptkbp:ATCCode |
A10AE04
|
| gptkbp:form |
injection
pre-filled pen vial |
| gptkbp:halfLife |
~19 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Toujeo
|
| gptkbp:indication |
gptkb:type_2_diabetes
type 1 diabetes |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
long-acting insulin analog
|
| gptkbp:powers |
300 units/mL
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:storage |
2–8°C (refrigerated)
|
| gptkbp:website |
https://www.toujeo.com/
|
| gptkbp:bfsParent |
gptkb:Sanofi
|
| gptkbp:bfsLayer |
5
|